In inflammatory bowel disease (IBD), the expression of CD39 in the FoxP3+ Treg immunophenotype is reduced, whereas an increase in CD39 expression is associated with a positive response to treatment. The gene discussed is FOXP3; the disease is inflammatory bowel disease.